LEMON BLOG

Implementing drug transparency in Malaysia presents a multifaceted set of challenges, encompassing regulatory, economic, political, and social dimensions.

The healthcare sector in Malaysia is rapidly digitizing, driven by government initiatives, private sector investments, and the increasing demand for efficient patient care. With this transformation comes a growing reliance on third-party vendors for software, cloud storage, medical devices, and IT infrastructure. However, third-party relationships also introduce significant risks, including data breaches, regulatory non-compliance, and service disruptions. Healthcare IT leaders must have a robust Third-Party Risk Management (TPRM) strategy to safeguard sensitive patient data and ensure seamless operations.